Thymoglobuline is an immunosuppressant for the prophylaxis of graft rejection in renal or heart transplantation and the treatment of steroid resistant graft rejection in renal transplantation.

Thymoglobuline is a polyclonal antibody that causes peripheral and central depletion of lymphocytes.

This depletion is thought to be the primary mechanism of immunosuppression and peripheral lymphocyte depletion can be detected as early as 24 hours after the first infusion.

Thymoglobuline should be used under strict medical supervision and prescribed by physicians with experience in using immunosuppressive agents.

View Thymoglobuline drug record

Further information: Genzyme

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases